LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Forconi, F. [1 ]
Fabbri, A. [1 ]
Lenoci, M. [1 ]
Sozzi, E. [1 ]
Bocchia, M. [1 ]
Gozzetti, A. [1 ]
Tassi, M. [1 ]
Raspadori, D. [1 ]
Lauria, F. [1 ]
机构：
[1] Univ Siena, I-53100 Siena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0093
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase IISWOG TRIAL 9706
    Hussein, MA
    Gundacker, H
    Head, DR
    Elias, L
    Foon, KA
    Boldt, DH
    Dobin, SM
    Dakhil, SR
    Budd, GT
    Appelbaum, FR
    LEUKEMIA, 2005, 19 (11) : 1880 - 1886
  • [32] Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997
    Flinn, Ian W.
    Neuberg, Donna S.
    Grever, Michael R.
    Dewald, Gordon W.
    Bennett, John M.
    Paietta, Elisabeth M.
    Hussein, Mohamad A.
    Appelbaum, Frederick R.
    Larson, Richard A.
    Moore, Dennis F., Jr.
    Tallman, Martin S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 793 - 798
  • [33] Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.
    Weiss, MA
    Lamanna, N
    Gencarelli, A
    Scheinberg, DA
    Maslak, PG
    Horgan, D
    BLOOD, 2002, 100 (11) : 365B - 365B
  • [34] Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
    Eichhorst, BF
    Busch, R
    Hopfinger, G
    Pasold, R
    Hensel, M
    Steinbrecher, C
    Siehl, S
    Jäger, U
    Bergmann, M
    Stilgenbauer, S
    Schweighofer, C
    Wendtner, CM
    Döhner, H
    Brittinger, G
    Emmerich, B
    Hallek, M
    BLOOD, 2006, 107 (03) : 885 - 891
  • [35] Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia
    Robak, Tadeusz
    Smolewski, Piotr
    Cebula, Barbara
    Grzybowska-Izydorczyk, Olga
    Blonski, Jerzy Z.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (02) : 107 - 113
  • [36] Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders
    Gozzetti, Alessandro
    Fabbri, Alberto
    Cencini, Emanuele
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1916 - 1917
  • [37] Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia
    Kasamon, YL
    Flinn, IW
    Grever, MR
    Diehl, LF
    Garrett-Mayer, E
    Goodman, SN
    Lucas, MS
    Byrd, JC
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8413 - 8417
  • [38] Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience
    Herishanu, Yair
    Tadmor, Tamar
    Braester, Andrei
    Bairey, Osnat
    Aviv, Ariel
    Rahimi-Levene, Naomi
    Fineman, Riva
    Levi, Itai
    Yuklea, Mona
    Ruchlemer, Rosa
    Shvidel, Lev
    Polliack, Aaron
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (02) : 185 - 192
  • [39] CHEMOIMMUNOTHERAPY WITH OFATUMUMAB, FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A PHASE II INTERNATIONAL TRIAL
    Wierda, G.
    Kipps, T.
    Duerig, J.
    Griskevicius, L.
    Stilgenbauer, S.
    Mayer, J.
    Smolej, L.
    Hess, G.
    Griniute, R.
    Hernandez-Ilizaliturri, F.
    Padmanabhan, S.
    Gorczyca, M.
    Gupta, I.
    Nielsen, T.
    Russell, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 320 - 321
  • [40] Fludarabine and cyclophosphamide: A highly active and well tolerated regimen for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Flinn, IW
    Byrd, JC
    Morrison, C
    Jamison, J
    Miller, C
    Christie, RJ
    Gore, S
    Burke, P
    Vogelsang, G
    Grever, MR
    BLOOD, 1998, 92 (10) : 104A - 104A
12345